Biotalys Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 55

Employees

  • Stock Symbol
  • BTLS

Stock Symbol

  • Share Price
  • $2.04
  • (As of Friday Closing)

Biotalys General Information

Description

Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.

Contact Information

Formerly Known As
AgroSavfe
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Buchtenstraat 11
  • Suzanne Tassierstraat
  • 9051 Ghent
  • Belgium
+32 09
Primary Industry
Agricultural Chemicals
Other Industries
Other Agriculture
Stock Exchange
BRU
Vertical(s)
Corporate Office
  • Buchtenstraat 11
  • Suzanne Tassierstraat
  • 9051 Ghent
  • Belgium
+32 09

Biotalys Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotalys Stock Performance

As of 13-Nov-2026, Biotalys’s stock price is $2.04. Its current market cap is $92.9M with 45.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.04 $2.11 $1.76 - $5.75 $92.9M 45.4M 21.6K -$0.50

Biotalys Financials Summary

As of 30-Jun-2026, Biotalys has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 155,745 132,823 116,082 135,283
Revenue 0 0 0 0
EBITDA (17,749) (15,957) (12,657) (20,735)
Net Income (19,559) (17,776) (14,271) (22,193)
Total Assets 25,802 23,174 38,238 40,438
Total Debt 3,697 4,441 5,045 6,713
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biotalys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biotalys‘s full profile, request access.

Request a free trial

Biotalys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Biotalys‘s full profile, request access.

Request a free trial

Biotalys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins f
Agricultural Chemicals
Ghent, Belgium
55 As of 2026

Londerzeel, Belgium
 

Newport Beach, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biotalys Competitors (2)

One of Biotalys’s 2 competitors is Bi-PA, a Corporate Backed or Acquired company based in Londerzeel, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bi-PA Corporate Backed or Acquired Londerzeel, Belgium
American Vanguard Corporation Newport Beach, CA
You’re viewing 2 of 2 competitors. Get the full list »

Biotalys Patents

Biotalys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229347-A1 Anti-fungal vhh antibodies Pending 29-Apr-2025
WO-2026153969-A1 Antifungal combinations Pending 14-Jan-2025
EP-4763860-A1 Method for vhh library construction Pending 20-Dec-2024
WO-2026087355-A1 Downstream processing Pending 22-Oct-2024
WO-2026008785-A1 Agrochemical compositions Pending 03-Jul-2024 A01P3/00
To view Biotalys’s complete patent history, request access »

Biotalys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotalys Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biotalys‘s full profile, request access.

Request a free trial

Biotalys ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

54.2 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Chemicals

Industry

of 502

Rank

Percentile

Agricultural Chemicals

Subindustry

of 69

Rank

Percentile

To view Biotalys’s complete esg history, request access »

Biotalys FAQs

  • When was Biotalys founded?

    Biotalys was founded in 2013.

  • Where is Biotalys headquartered?

    Biotalys is headquartered in Ghent, Belgium.

  • What is the size of Biotalys?

    Biotalys has 55 total employees.

  • What industry is Biotalys in?

    Biotalys’s primary industry is Agricultural Chemicals.

  • Is Biotalys a private or public company?

    Biotalys is a Public company.

  • What is Biotalys’s stock symbol?

    The ticker symbol for Biotalys is BTLS.

  • What is the current stock price of Biotalys?

    As of 13-Nov-2026 the stock price of Biotalys is $2.04.

  • What is the current market cap of Biotalys?

    The current market capitalization of Biotalys is $92.9M.

  • Who are Biotalys’s competitors?

    Bi-PA and American Vanguard are competitors of Biotalys.

  • What is Biotalys’s annual earnings per share (EPS)?

    Biotalys’s EPS for 12 months was -$0.50.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process